DDB Beats Out 3 for Merck's Singulair Biz

New YORK—DDB Worldwide has landed ad duties on Singulair, an anti-asthma drug from Merck & Co., the client comfirmed. Billings are estimated at more than $40 million.

DDB bested fellow New York shops McCann-Erickson Worldwide, J. Walter Thompson and FCB Worldwide. FCB was the incumbent.

The assignment encompasses creative and media planning duties for the prescription drug, which is sold in tablet form.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in